| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/01/2007 | CA2619396A1 Solid pharmaceutical composition comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine and a ph modifier |
| 03/01/2007 | CA2619035A1 Pharmaceutical compositions |
| 03/01/2007 | CA2617507A1 Device, system, and method comprising microencapsulated proton donor for release of nitric oxide from a polymer |
| 03/01/2007 | CA2609948A1 Vasoactive kit and composition and uses thereof |
| 03/01/2007 | CA2598746A1 Oral care compositions |
| 02/28/2007 | EP1757695A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757694A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757603A1 Therapeutic agent for keratoconjunctiva disorder |
| 02/28/2007 | EP1757569A2 Process for making purified hydrofluoroalcane, purified hydrofluoroalcane and a method for analysing a hydrofluoroalcane |
| 02/28/2007 | EP1757321A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 02/28/2007 | EP1757314A1 Functionalized derivatives of hyaluronic acid, formation of hydrogels and in situ using same |
| 02/28/2007 | EP1757312A1 Freeze-dried composition of inactivated virus envelope with membrane fusion activity |
| 02/28/2007 | EP1757310A1 Surface-modified and solubility-improved hard capsule |
| 02/28/2007 | EP1757309A1 Adhesive material |
| 02/28/2007 | EP1757308A1 Preparation for oral administration |
| 02/28/2007 | EP1757303A1 Human lysozyme medicine, its manufacturing method and application thereof |
| 02/28/2007 | EP1757300A1 Agent for removing factor causing circulatory dysfunction |
| 02/28/2007 | EP1757294A1 Orally-administered aqueous risperidone solution |
| 02/28/2007 | EP1757293A1 Bh4-responsive hyperphenylalaninemia remedies |
| 02/28/2007 | EP1757291A2 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-YL)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof |
| 02/28/2007 | EP1757281A2 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| 02/28/2007 | EP1757280A1 Transdermal patch for administering sufentanyl |
| 02/28/2007 | EP1757279A1 Dissolvable film |
| 02/28/2007 | EP1757278A1 Device, system, and method comprising microencapsulated liquid for release of nitric oxide from a polymer |
| 02/28/2007 | EP1757277A1 Oral preparations and process for production thereof |
| 02/28/2007 | EP1757276A1 Method of producing nano- and microcapsules of spider silk protein |
| 02/28/2007 | EP1757275A1 Seamless capsule containing water-soluble active ingredient |
| 02/28/2007 | EP1757274A1 Effervescent composition against cold symptoms |
| 02/28/2007 | EP1757273A1 Preparation for oral administration |
| 02/28/2007 | EP1757272A2 Drug-release system and its use |
| 02/28/2007 | EP1757271A1 Solid pharmaceutical preparation with improved stability and process for producing the same |
| 02/28/2007 | EP1757270A1 Liposomal formulations |
| 02/28/2007 | EP1757269A2 Pulmonary formulation comprising silicon particles |
| 02/28/2007 | EP1757268A1 Dry-form composition for oral ingestion and gel-form composition for oral ingestion of type prepared at time of use |
| 02/28/2007 | EP1757267A2 Mucosal delivery tablet |
| 02/28/2007 | EP1757250A2 Implantabel stent prosthesis |
| 02/28/2007 | EP1757240A1 Valved intradermal delivery device |
| 02/28/2007 | EP1756226A1 Silicone vesicles |
| 02/28/2007 | EP1756039A2 Compounds and compositions for delivering active agents |
| 02/28/2007 | EP1755733A2 Methods and devices for thermal treatment |
| 02/28/2007 | EP1755691A2 Antimicrobial articles |
| 02/28/2007 | EP1755682A1 Solid pharmaceutical formulation |
| 02/28/2007 | EP1755677A2 High pressure spray-dry of bioactive materials |
| 02/28/2007 | EP1755672A2 Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases |
| 02/28/2007 | EP1755666A1 Vaccine compositions comprising virosomes and a saponin adjuvant |
| 02/28/2007 | EP1755650A2 A biomolecule-containing formulation of increased stability |
| 02/28/2007 | EP1755647A1 Treatment of amyotrophic lateral sclerosis |
| 02/28/2007 | EP1755636A1 Sustained release composition |
| 02/28/2007 | EP1755635A1 Treatment of inflammatory airway disease |
| 02/28/2007 | EP1755633A1 Oral delivery of peptide pharmaceutical compositions |
| 02/28/2007 | EP1755630A1 Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use |
| 02/28/2007 | EP1755623A1 Treatment of lung diseases and pre-lung disease conditions |
| 02/28/2007 | EP1755617A1 Perfluorocarbon-soluble compounds |
| 02/28/2007 | EP1755578A2 Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance |
| 02/28/2007 | EP1755575A2 Antifungal drug delivery |
| 02/28/2007 | EP1755570A1 Transdermal drug delivery device comprising extensor-relaxor means |
| 02/28/2007 | EP1755569A1 Wound dressing |
| 02/28/2007 | EP1755568A1 Controlled release formulation for oral administration of metformin |
| 02/28/2007 | EP1755567A2 Drug delivery product and methods |
| 02/28/2007 | EP1755566A2 Stable pharmaceutical formulations of benzimidazole compounds |
| 02/28/2007 | EP1755565A2 Soft gelatin capsule comprising omega-3 polyunsaturated fatty acid |
| 02/28/2007 | EP1755564A2 Immediate release pharmaceutical tablets with height greater than width |
| 02/28/2007 | EP1755563A1 Pharmaceutical tablets comprising two or more unitary segments |
| 02/28/2007 | EP1755562A1 Folic acid-containing contraceptive |
| 02/28/2007 | EP1755561A2 Multi-layer tablet comprising non-steroidal anti-inflammatory drugs decongestants and non-sedating antihistamines |
| 02/28/2007 | EP1755560A1 Pharmaceutical tablets having a relatively inactive segment |
| 02/28/2007 | EP1755559A1 Bioavailable solid dosage forms of metaxalone |
| 02/28/2007 | EP1755558A1 Dry powder pharmaceutical composition, its preparation process and stable aqueous suspension obtained from such composition |
| 02/28/2007 | EP1755557A1 Micropellet containing pellets and method of preparing such pellets |
| 02/28/2007 | EP1755556A2 Directly compressible tricalcium phosphate |
| 02/28/2007 | EP1755555A2 Dry powder compositions of glycopyrrolate |
| 02/28/2007 | EP1755554A2 Heat sterilization of glucocorticosteroids |
| 02/28/2007 | EP1755553A1 A multi-phased personal care composition |
| 02/28/2007 | EP1755552A1 Oral care film |
| 02/28/2007 | EP1755551A2 Dpi formulation containing sulfoalkyl ether cyclodextrin |
| 02/28/2007 | EP1755540A2 Oral care compositions |
| 02/28/2007 | EP1755538A2 Cleansing and rinse solutions for skin and hair and method of using |
| 02/28/2007 | EP1755533A1 Vesicles of high molecular weight silicone polyethers |
| 02/28/2007 | EP1755402A2 Compositions for inhalation therapy and methods of use |
| 02/28/2007 | EP1755388A1 Mixed co-crystals and pharmaceutical compositions comprising the same |
| 02/28/2007 | EP1691892B1 Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same |
| 02/28/2007 | EP1551375B1 Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant |
| 02/28/2007 | EP1513532B1 Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein |
| 02/28/2007 | EP1454928B1 Process for production of water-soluble (meth)acrylic polymers, water-soluble (meth)acrylic polymers, and use thereof |
| 02/28/2007 | EP1379229B1 A jasmonate pharmaceutical composition for treatment of cancer |
| 02/28/2007 | EP1335710B8 Soft capsules comprising a starch mixture having a reduced branching degree |
| 02/28/2007 | EP1317254B1 Sustained release particle dispersion |
| 02/28/2007 | EP1296685B1 Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
| 02/28/2007 | EP1212091B1 Polyoxyalkylene copolymers containing pourable liquid vehicles |
| 02/28/2007 | EP1178811B1 Electrolyte gels for maintaining hydration and rehydration |
| 02/28/2007 | EP1151756B1 Kit comprising polyacrylamide gel for forming a capsule in the tissue of a mammal organism and allogenic or xenogenous cells of an animal, method for therapy of oncological diseases and the diabetes mellitus |
| 02/28/2007 | EP1096937B9 Sustained release ranolazine formulations |
| 02/28/2007 | EP1085811B1 Broad specificity dna damage endonuclease |
| 02/28/2007 | EP1079802B1 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention |
| 02/28/2007 | CN1922197A Targeted delivery of rna interference molecules |
| 02/28/2007 | CN1921896A Haemostatic sprays and compositions |
| 02/28/2007 | CN1921888A Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same |
| 02/28/2007 | CN1921887A Soft capsule preparation |
| 02/28/2007 | CN1921880A Protein drug sustained-release microparticle preparation for injection and process for producing the same |
| 02/28/2007 | CN1921878A Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |